Capricor Therapeutics Inc.

In News

CAPR Stock Surges 67% After-Hours — Is There Still A Path Forward For Deramiocel? - Stocktwits

Stocktwits - Oct 18, 2026

Capricor Therapeutics, Inc. (CAPR) options chain - Yahoo Finance Australia

Yahoo Finance Australia - Oct 16, 2026

Capricor Therapeutics, Inc. (CAPR) Discusses HOPE-3 Open-Label Extension Data and Deramiocel Update for Duchenne Muscular Dystrophy - Slideshow (NASDAQ:CAPR) 2026-10-13 - Seeking Alpha

Seeking Alpha - Oct 13, 2026

Voting power over 1.67M Capricor (CAPR) shares is shared by three reporting parties. - Stock Titan

Stock Titan - Oct 14, 2026

Millennium Management Trims Capricor Therapeutics (CAPR) Stake b - GuruFocus

GuruFocus - Oct 15, 2026

Analysts Expect Breakeven For Capricor Therapeutics, Inc. (NASDAQ:CAPR) Before Long - Simply Wall Street

Simply Wall Street - Oct 09, 2026

What's Going On With Capricor Therapeutics Stock Monday? - Benzinga

Benzinga - Oct 05, 2026

CAPR Alert: Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors Urged to Contact Hagens Berman; Securities Fraud Class Action Filed, September 28, 2026 Lead Plaintiff Deadline - PR Newswire

PR Newswire - Sep 28, 2026

Capricor Therapeutics Announces Extension of PDUFA Target - GlobeNewswire

GlobeNewswire - Aug 24, 2026

Capricor Therapeutics Soars As FDA Keeps Deramiocel Path Alive - StocksToTrade

StocksToTrade - Aug 17, 2026

Capricor’s FDA Fate Divides Wall Street And Investors: One Analyst Sees A $2 Stock But Retail Holds Out Hope - Stocktwits

Stocktwits - Oct 15, 2026

After a year on placebo, patients’ arm-function decline rate was 76% lower on treatment - Stock Titan

Stock Titan - Oct 05, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment